BSE Live
Apr 21, 11:16Prev. Close
887.80
Open Price
900.00
Bid Price (Qty.)
918.00 (50)
Offer Price (Qty.)
920.00 (10)
NSE Live
Apr 21, 11:16Prev. Close
889.00
Open Price
907.95
Bid Price (Qty.)
918.30 (1)
Offer Price (Qty.)
920.05 (143)
| Cash Flow of TTK Healthcare (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 108.33 | 84.12 | 838.07 | 57.78 | 37.05 | |
| Net CashFlow From Operating Activities | -3.98 | -4.94 | -26.08 | 45.00 | 96.42 | |
| Net Cash Used In Investing Activities | 20.10 | 28.49 | 32.96 | -30.55 | -77.24 | |
| Net Cash Used From Financing Activities | -18.08 | -21.91 | -12.43 | -9.14 | -17.16 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.95 | 1.64 | -5.54 | 5.31 | 2.03 | |
| Cash And Cash Equivalents Begin of Year | 10.96 | 9.32 | 14.86 | 9.55 | 7.53 | |
| Cash And Cash Equivalents End Of Year | 9.01 | 10.96 | 9.32 | 14.86 | 9.55 |
23.01.2026
TTK Healthcare Standalone December 2025 Net Sales at Rs 209.30 crore, up 2.22% Y-o-Y
20.10.2025
TTK Healthcare Standalone September 2025 Net Sales at Rs 203.57 crore, up 2.56% Y-o-Y
17.10.2025
TTK Healthcare Standalone September 2025 Net Sales at Rs 203.57 crore, up 2.56% Y-o-Y
05.08.2025
TTK Healthcare Standalone June 2025 Net Sales at Rs 226.43 crore, up 8.91% Y-o-Y
23.01.2026
TTK Healthcare Standalone December 2025 Net Sales at Rs 209.30 crore, up 2.22% Y-o-Y
20.10.2025
TTK Healthcare Standalone September 2025 Net Sales at Rs 203.57 crore, up 2.56% Y-o-Y
17.10.2025
TTK Healthcare Standalone September 2025 Net Sales at Rs 203.57 crore, up 2.56% Y-o-Y
05.08.2025
TTK Healthcare Standalone June 2025 Net Sales at Rs 226.43 crore, up 8.91% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth